Table 2 Drugs Commonly Skin Tested
| Â | Europe, n (%) | Asia Pacific, n (%) | North America, n (%) | Latin America, n (%) | Africa Middle East, n (%) | Region Not Specified, n (%) | Total (n = 72), n (%) |
|---|---|---|---|---|---|---|---|
Penicillins | 26 (36.1) | 15 (20.8) | 6 (8.3) | 8 (11.1) | 6 (8.3) | 2 (2.6) | 63 (87.5) |
Cephalosporins | 25 (34.7) | 14 (19.4) | 6 (8.3) | 7 (9.7) | 2 (2.6) | 2 (2.6) | 56 (77.8) |
Local anesthetic agents | 28 (38.9) | 8 (11.1) | 7 (9.7) | 7 (9.7) | 2 (2.6) | 2 (2.6) | 54 (75.0) |
General anesthetic agents | 25 (34.7) | 4 (5.6) | 4 (5.6) | 7 (9.7) | 2 (2.6) | 2 (2.6) | 44 (61.1) |
Non-beta lactam antibiotics | 21 (29.2) | 6 (8.3) | 3 (4.2) | 4 (5.6) | 1 (1.4) | 1 (1.4) | 36 (50.0) |
Non-steroidal anti-inflammatory drugs | 15 (20.8) | 6 (8.3) | 2 (2.6) | 4 (5.6) | 1 (1.4) | 1 (1.4) | 29 (40.3) |